Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study)

CONCLUSIONS: This comparative effectiveness study of a contemporary cohort of adults with type 2 diabetes, largely without established cardiovascular disease, suggests that liraglutide treatment may reduce the risk of cardiovascular events in patients at relatively low risk compared with other commonly used glucose-lowering medications.REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01794143.PMID:38344820 | DOI:10.1161/CIRCULATIONAHA.123.066604

Source: Circulation - February 12, 2024 Category: Cardiology Authors: Jennifer B Green Brendan M Everett Alokananda Ghosh Naji Younes Heidi Krause-Steinrauf Joshua Barzilay Cyrus Desouza Silvio E Inzucchi Yashashwi Pokharel David Schade Alexandra Scrymgeour Meng H Tan Kristina M Utzschneider Sunder Mudaliar GRADE Study Rese Source Type: research